GFL
BMY icon

Granite FO LLC’s Bristol-Myers Squibb BMY Stock Holding History

Granite FO LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,596
Closed -$127K – 76
2024
Q1 		$127K Hold
2,596
– – 0.07% 63
2023
Q4 		$133K Hold
2,596
– – 0.09% 66
2023
Q3 		$151K Hold
2,596
– – 0.11% 57
2023
Q2 		$166K Sell
2,596
-3,500
-57% -$235K 0.11% 54
2023
Q1 		$407K Buy
+6,096
New +$430K 0.25% 48

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Granite FO LLC's BMY Position: Q2 2024 in Review

Granite FO LLC sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 2,596 shares — an estimated $127K sold.

Granite FO LLC first reported a position in BMY in Q1 2023 and held it in 5 quarters. The position peaked at $407K in Q1 2023. 2,153 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • Granite FO LLC reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • Granite FO LLC sold 2,596 Bristol-Myers Squibb shares in Q2 2024, an estimated $127K.
  • Granite FO LLC first reported a position in Bristol-Myers Squibb in Q1 2023 and held it in 5 quarters.
  • Granite FO LLC's Bristol-Myers Squibb position peaked at $407K in Q1 2023.
  • 2,153 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Granite FO LLC's 13F filing for Q2 2024, filed 16 Aug 2024.